Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre- and Post-Operative FOLFOX Versus Surgery Alone in Resectable Colorectal Liver Metastases
NCT00006479Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 13
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid in colorectal cancer (CRC), liver metastasis, sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)liver metastasis
Beyond the preview
Go deeper on NCT00006479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006479.